(1)
Hjortsberg, C.; Persson, U.; Lidbrink, E.; Bennett, C. Cost-Effectiveness Analysis of Pegylated-Liposomal Doxorubicin and Liposomal Daunorubicin Treatments in Patients With Kaposi’s Sarcoma. AO 1999, 38, 1063-1067.